Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05909111

MR-Only Based Adaptive External Beam Radiation Therapy of Cervical Cancer on Ethos Therapy: Feasibility Study

Current management of patients treated with External Beam Radiation Therapy (EBRT) for cervical cancer with a classical Image-guided Radiation Therapy (IGRT) strategy involves a complex, not entirely satisfactory, treatment workflow. Indeed, in our institution, two workflows have been designed to take into account the inter-fraction motion of cervix and uterus : an Internal Target Volume (ITV)-based approach and a plan of the day strategy requiring both several planning-CT (Computed Tomography) acquisitions with variable bladder filling.The upcoming installation of a Varian Ethos therapy system in our institution will allow us to implement a less cumbersome online adaptive radiotherapy strategy (oART), which, by conforming to the daily anatomy, will enable a reduction in the Clinical Target Volume (CTV) to Planning Target Volume (PTV) margins leading to an expected reduction in dose delivered to organs at risk (OAR) .On the other hand, MR (Magnetic Resonance)-only treatment planning is playing an increasing role in radiotherapy, notably in the treatment of prostate cancer. MR-only workflows are known (a) to provide the most reliable delineation in soft tissues and (b) to decrease spatial uncertainties by suppressing the Magnetic Resonance Imaging (MRI)-CT co-registration. Regarding the management of cervical cancer, the importance of MRI is well established and its use becomes essential. Combining a MR-only workflow with an adaptative one on the Varian Ethos system, could lead to an improved management of patients treated for cervical cancer with an expected reduction in margins and volumes treated (thanks to MRI delineation and online adaptation) and therefore a reduction of OAR toxicity. Including regular multi-parametric MR imaging during and after the course of the treatment could also provide in the future an assessment of the treatment response. One of the important challenges in developing this specific workflow is to have a reliable synthetic CT (derived from MRI) to (a) provide electron or mass density for treatment planning calculations and (b) allow accurate online repositioning/deformation with Ethos Cone Beam Computed Tomography (CBCT). The other fundamental challenge is to provide a formal assessment of the clinical benefit of introducing MR-only simulation and planning in an oART workflow.

This project aims to demonstrate the feasibility of setting up an adaptive workflow on the ETHOS platform with the sole use of MR patient image.The project is divided into two parts. The first part consists in demonstrate the feasibility of the workflow on 15 patients with cervix cancer.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Institut Sainte Catherine

Avignon, France

Location status: Recruiting

Location contact

Antoine Arnaud, DM

CONTACT

[email protected]

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age > 18 years old
  • Histologically proven cervical cancer (SCC, ADK ou adenous-SCC)
  • Patient for curative RTCT treatment
  • FIGO/TNM Stage IB2, IIA, IIB, IIIA, IIIB with or without lymph nodes involvement
  • WHO < 2
  • No pregnancy
  • Informed consent dated and signed
  • Patient affiliated or beneficiary of a social security scheme
  • Free, informed and written consent signed by the participant and the investigator (at the latest on the day of inclusion and before any examination required by the research).

Exclusion criteria

  • Metastatic disease
  • Contraindications to IRM examinations (claustrophobia, presence of metallic elements..)
  • Signes of active infection or serious health problems
  • Historic of abdominal or pelvis RT
  • Surgical history: partial or total hysterectomy

Treatment and study plan

Magnetic Resonance Imaging

Diagnostic Test

MRI weekly during the radiation treatment course (5 RMI added to the standard care)

Primary outcomes

  1. Tumor regression assessment CBCT

    Time frame: 18 months

    Volume Tumor regression on CBCT

  2. Tumor regression assessment MRI

    Time frame: 18 months

    Volume Tumor regression on MRI

Study contacts

Contact information is provided by the study sponsor or research team.

Aurélien Badey

CONTACT

[email protected]

0490276563

Catherine Khamphan, PhD

CONTACT

[email protected]

0490276543

Sponsors and collaborators

Lead sponsor

Recherche clinique

Other

Collaborators

  • Varian Medical Systems

Registry information

Official study title

MR-Only Based Adaptive External Beam Radiation Therapy of Cervical Cancer on Ethos

Acronym: Ethos Col

Important dates

Study start
2022
Primary completion
2025
Study completion
2026
First posted
Jun 18, 2023
Registry last updated
Jan 22, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.